Influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) Injectable Suspension
RxNorm 2563009
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2563009 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) Injectable Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 mg/ML / influenza B virus B/Washington/02/2019 antigen 0.03 mg/ML Injectable Suspension
(Atom ID: 12656916)
PSN
Prescribable Name (PSN):
Influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) Injectable Suspension
(Atom ID: 12659185)
SY